Back Nauck, MA, Klein, N, rskov, C, et al (Aug 1993) 'Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients', Diabetologia , 36/8, 741-4
Potential side effects may include nausea, vomiting, constipation, diarrhea, upset stomach, injection site irritation, low blood sugar in certain settings, and allergic reactions
Navigating these social changes is an important but often overlooked aspect of the GLP-1 transformation journey
For patients who need it, doses can reach 2.0 mg, 2.4 mg, or the compounded maximum of 2.5 mg weekly
So unlike a lot of chemicals, these hormones are likely to do what they're supposed to do and not to cause too much trouble